Colin Ripsman provides an investment outlook on what pension funds should expect for the year ahead
'The pension gap has grown only by two per cent since 1976,' writes HOOPP's head of plan services
As plan sponsors consider the costs and efficacy of GLP-1 drugs, they should not ignore alternatives
A multi-manager, multi-strategy approach to private markets investing can optimize for returns, volatility and liquidity
